Emotional analysis technology developed by software solutions provider Opsis Emotion AI will be piloted over the next two years in a programme targeting more than 4,300 seniors in Singapore.
The programme will see a collaboration between Opsis and social services agency Lions Befrienders (LB). Through the use of Opsis' emotion analysis software, counsellers from LB are expected to be able to...
AI diagnostics startup MediCircle Health has recently introduced in India a rapid spectrometry-based test that employs machine learning and artificial intelligence to detect COVID-19.
WHAT IT DOES
Spectral Instant Test (SpectraLIT) is a point-of-care diagnostic platform that performs spectral analysis to accurately and instantly determine if a spectral pattern of a virus from a nasal or mouthwash...
Pharmacy IT solutions provider Fred IT unveiled on Tuesday a new pharmacy dispensing platform powered by artificial intelligence.
WHAT IT DOES
The company says the Fred Dispense Plus platform is an improvement from the widely used Fred Dispense Australia platform.
Among its features, the Fred AID (Artificial Intelligence Directions) tool uses AI and big data to support clinical and business...
Tech-enabled drug discovery company Valo Health announced today plans to go public through a $2.8 billion SPAC deal with Khosla Ventures Acquisition Co., a special purpose acquisition company from Khosla Ventures.
The deal, which is expected to close in the third quarter of this year, will deliver approximately $168.5 million in proceeds in private investment in public equity (PIPE) funding from...
Indonesian health startup Prixa has raised $3 million in an investment round led by Telkom Indonesia's MDI Ventures and Trans-Pacific Technology Fund and joined by publicly-listed Siloam Hospitals Group.
WHY IT MATTERS
The fresh funds will be used to scale its platform and user base while supporting its existing B2B customers and improving healthcare access and digital health transformation in...
A team of researchers at the University of Western Australia is coming up with an artificial intelligence-based risk assessment tool to better detect plaque in heart computed tomography scans.
WHY IT MATTERS
The research team comprising AI and cardiac imaging experts was recently awarded a grant worth AU$896,606 (about $695,000) from the government's Medical Research Future Fund to develop a tool...
Australian smartphone-based medical imaging company Advanced Human Imaging disclosed last week that it received a CE Mark for the dermatology artificial intelligence component in its DermaScan SaaS platform.
WHY IT MATTERS
According to the company, the DermaScan AI can accurately classify skin conditions from a photo captured by a smartphone camera. Using a large database, it can classify 588...
A study has demonstrated the international transferability of a Taiwanese artificial intelligence model for detecting medication errors in EHR systems in the United States.
The study was jointly conducted by Taiwan-based medical AI startup Aesop Technology, Taipei Medical University, Harvard Medical School and Brigham and Women's Hospital. Its results were announced last week in a press release....
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).
This is the first collaboration between the two companies, pairing Ferring’s medical expertise with CytoReason’s artificial intelligence (AI) platform to build cell-centred disease models.
CytoReason is developing a...
Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte for the production and sale of a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics.
WHAT IT'S FOR
Sysmex has been acquiring technologies for analysing cells, genes, and proteins with a high degree of...
.jpg?itok=9G0Ofi7Z)
_0.jpeg?itok=NpCbFI32 "The collaboration will use AI technology to accelerate the drug discovery process.")
